The report "Womens Health Diagnostics Market Size, Growth by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) - Global Forecast to 2025" is projected to reach USD 36.6 billion by 2025, at a CAGR of 7.9%
Browse 248 market data Tables and 43 Figures spread through 270 Pages and in-depth TOC on "Women’s Health Diagnostics Market – Global Forecast to 2025"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html
Currently, the market is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe. The increasing adoption of POC diagnostic testing and the growth in the number of diagnostic and imaging centers are also expected to support the growth of this market during the forecast period. However, the high cost of diagnostic devices, tests, and procedures; shortage of skilled laboratory technicians; and insufficient reimbursements for diagnostic tests are expected to restrain this markets growth to a certain extent.
The prenatal genetic screening & carrier testing segment is expected to grow at the highest CAGR during the forecast period
Based on application, the women’s health diagnostics market is segmented into osteoporosis testing, OVC testing, cervical cancer testing, breast cancer testing, pregnancy & fertility testing, prenatal genetic screening & carrier testing, infectious disease testing, STD testing, and ultrasound tests. The prenatal genetic screening & carrier testing segment is projected to witness the highest growth in the women’s health diagnostics market during the forecast periods (2020-2025). Growth in this segment is driven mostly by the adverse effects of Down’s syndrome, Edwards’ syndrome, CF, and TORCH infections in infants, and increasing awareness among women regarding prenatal screening for these disorders.
The hospitals & clinics segment is expected to account for the largest share of the women’s health diagnostics market
Based on end user, the women’s health diagnostics market is segmented into hospitals & clinics, diagnostic & imaging centers, and home care settings. The hospitals & clinics segment accounted for the largest share of the women’s health diagnostics market. The large share of this segment can be attributed to a greater proportion of patients (women) visiting hospitals to diagnose/treat health issues. Other factors such as growing consolidation among hospitals and the implementation of ACOs in the US are also expected to support the growth of this end-user segment in the coming years.
Asia Pacific is expected to account for the highest CAGR for players operating in the women’s health diagnostics market
The Asia Pacific women’s health diagnostics market is expected to grow at the highest CAGR from 2020 to 2025. Improving healthcare infrastructures, growing per capita incomes, and the rising focus of key market companies in this region are major factors driving the growth of the APAC women’s health diagnostics market. Countries like India, China, and South Korea are expected to offer significant growth opportunities for companies operating in this market. This can primarily be attributed to rapid growth in the overall disease population in these countries, the epidemiological shift from infectious diseases to chronic diseases, and the increasing income of the middle-class population in these countries.
The prominent players in this market are Quest Diagnostics Incorporated (US), Hologic, Inc. (US), Abbott Laboratories (US), Siemens AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), General Electric Company (US), and Becton, Dickinson and Company (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441